Hennion & Walsh Asset Management »

BioCryst Pharmaceuticals shares owned by Hennion & Walsh Asset Management

Quarter-by-quarter ownership of BioCryst Pharmaceuticals (BCRX) shares owned by Hennion & Walsh Asset Management from 13F filings

Historical chart of Hennion & Walsh Asset Management investment in BioCryst Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including BioCryst Pharmaceuticals held by Hennion & Walsh Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in BioCryst Pharmaceuticals by Hennion & Walsh Asset Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $651k 86k 7.59
2025-06-30 $452k 51k 8.96

More positions owned by Hennion & Walsh Asset Management

Ishares Tr Core S&p500 Etf (IVV)
Goldman Sachs Etf Tr Activebeta Us Lg (GSLC)
Wisdomtree Tr Dynamic Intl Eqt (DDWM)
Goldman Sachs Etf Tr Activebeta Int (GSIE)
Proshares Tr S&p 500 High Inc (ISPY)
Vanguard Index Fds Value Etf (VTV)
Ishares Tr Investment Grade (IGEB)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
NVIDIA Corporation (NVDA)
Broadcom (AVGO)
Columbia Etf Tr Ii Em Core Ex Etf (XCEM)
Ishares Tr Pfd And Incm Sec (PFF)
Pimco Municipal Income Fund II (PML)
Alphabet Cap Stk Cl A (GOOGL)
Nuveen Muni Value Fund (NUV)

View all positions for Hennion & Walsh Asset Management

Top funds holding BioCryst Pharmaceuticals

Vanguard Group
BlackRock
Deerfield Management Company
State Street Corporation
Kynam Capital Management
UBS Group
Alkeon Capital Management
Morgan Stanley
Arrowstreet Capital, Limited Partnership
Geode Capital Management
Two Sigma Investments
Two Sigma Advisers
Hood River Capital Management
Nuveen
Assenagon Asset Management

View all funds holding BioCryst Pharmaceuticals